VT-EBV-N for Treatment of Severe in EBV Positive Extranodal NK/T Cell Lymphoma Patients

NCT03671850 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Extranodal NK/T-cell Lymphoma

Interventions

BIOLOGICAL: VT-EBV-N
OTHER: Placebo

Sponsor

ViGenCell Inc.